factually
Index/Topics/NeuroXPF COVID-19 Claims

NeuroXPF COVID-19 Claims

The FDA issued a warning letter to NeuroXPF for making misleading claims about preventing or treating COVID-19.

Fact-Checks

1 result
Jan 26, 2026
Most Viewed

Has the FDA issued warning letters or enforcement actions related to NeuroMax or similarly named products?

The has taken enforcement actions tied to products with names similar to "": the agency issued a warning letter to an entity marketing "" for unapproved COVID-related claims (NeuroXPF, 03/31/2020) and...